SRXH
Income statement / Annual
Last year (2025), SRX Health Solutions Inc.'s total revenue was $6.53 M,
a decrease of 87.01% from the previous year.
In 2025, SRX Health Solutions Inc.'s net income was -$45.01 M.
See SRX Health Solutions Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
09/30/2025 |
12/31/2024 |
09/29/2023 |
09/29/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
08/31/2018 |
08/31/2017 |
08/31/2016 |
| Operating Revenue |
$6.53 M |
$50.30 M |
$118.94 M |
$92.63 M |
$58.63 M |
$54.38 M |
$20.75 M |
$617.01 |
$2.16 K |
$62.65 |
| Cost of Revenue |
$5.04 M
|
$31.80 M
|
$95.33 M
|
$79.33 M
|
$41.17 M
|
$36.06 M
|
$13.04 M
|
$274.08
|
$416.89
|
$2.86 K
|
| Gross Profit |
$1.50 M
|
$18.49 M
|
$23.61 M
|
$13.31 M
|
$17.47 M
|
$18.32 M
|
$7.71 M
|
$342.93
|
$1.75 K
|
-$2.80 K
|
| Gross Profit Ratio |
0.23
|
0.37
|
0.2
|
0.14
|
0.3
|
0.34
|
0.37
|
0.56
|
0.81
|
-44.72
|
| Research and Development Expenses |
$0.00
|
$143.81 K
|
$132.55 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$26.55 M
|
$13.14 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$2.95 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$13.03 M
|
$26.93 M
|
$29.49 M
|
$13.14 M
|
$39.49 M
|
$53.21 M
|
$53.72 M
|
$686.05 K
|
$655.84 K
|
$272.23 K
|
| Other Expenses |
$0.00
|
$0.00
|
-$207.65 K
|
$1.33 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$13.03 M
|
$27.07 M
|
$29.42 M
|
$14.47 M
|
$39.49 M
|
$53.21 M
|
$53.72 M
|
$686.05 K
|
$655.84 K
|
$272.23 K
|
| Cost And Expenses |
$18.06 M
|
$58.88 M
|
$124.75 M
|
$93.80 M
|
$80.66 M
|
$89.27 M
|
$66.76 M
|
$686.32 K
|
$656.26 K
|
$275.10 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$628.00 K
|
$671.59 K
|
$2.05 M
|
$753.71 K
|
$4.10 M
|
$11.81 M
|
$892.51 K
|
$1.42 M
|
$1.04 M
|
$537.68 K
|
| Depreciation & Amortization |
$31.00 K
|
$186.95 K
|
$1.70 M
|
$627.01 K
|
$2.12 M
|
$2.23 M
|
$282.41 K
|
$0.00
|
$0.00
|
$2.86 K
|
| EBITDA |
-$11.50 M |
$629.88 K |
-$7.05 M |
-$539.40 K |
$10.58 M |
-$61.72 M |
-$45.72 M |
-$685.70 K |
-$654.09 K |
-$272.18 K |
| EBITDA Ratio |
-1.76
|
0.01
|
-0.06
|
-0.01
|
0.18
|
-1.14
|
-2.2
|
-1111.33
|
-302.26
|
-4344.39
|
| Operating Income Ratio |
-1.76
|
-0.17
|
-0.05
|
-0.01
|
-0.38
|
-0.64
|
-2.22
|
-1111.33
|
-302.26
|
-4390.01
|
| Total Other Income/Expenses Net |
$2.89 M
|
$8.35 M
|
-$5.13 M
|
-$842.77 K
|
$26.39 M
|
-$40.88 M
|
-$199.72 M
|
-$762.52 K
|
-$1.52 M
|
-$943.66 K
|
| Income Before Tax |
-$8.64 M
|
-$228.66 K
|
-$10.94 M
|
-$2.01 M
|
$4.36 M
|
-$75.76 M
|
-$245.72 M
|
-$1.45 M
|
-$2.18 M
|
-$1.22 M
|
| Income Before Tax Ratio |
-1.32
|
-0
|
-0.09
|
-0.02
|
0.07
|
-1.39
|
-11.84
|
-2347.16
|
-1005.5
|
-19452.37
|
| Income Tax Expense |
$0.00
|
$12.94 K
|
$196.58 K
|
$440.21 K
|
$47.16 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$45.01 M
|
-$241.60 K
|
-$11.14 M
|
-$2.45 M
|
$3.80 M
|
-$75.76 M
|
-$245.72 M
|
-$14.27 M
|
-$2.18 M
|
-$1.22 M
|
| Net Income Ratio |
-6.89
|
-0
|
-0.09
|
-0.03
|
0.06
|
-1.39
|
-11.84
|
-23134.31
|
-1005.5
|
-19452.37
|
| EPS |
-2.13 |
-0.14 |
-0.9 |
-3.48 |
8.4 |
-408.21 |
-1952.83 |
-1239.34 |
-171.35 |
-89.59 |
| EPS Diluted |
-2.13 |
-0.14 |
-0.9 |
-3.48 |
7.65 |
-408.21 |
-1952.83 |
-1239.34 |
-171.35 |
-89.59 |
| Weighted Average Shares Out |
$21.11 M
|
$1.62 M
|
$12.39 M
|
$704.18 K
|
$452.91 K
|
$185.93 K
|
$125.90 K
|
$11.54 K
|
$11.35 K
|
$10.27 K
|
| Weighted Average Shares Out Diluted |
$21.11 M
|
$1.62 M
|
$12.39 M
|
$704.18 K
|
$497.79 K
|
$185.93 K
|
$125.90 K
|
$11.54 K
|
$11.35 K
|
$10.27 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
